The DOI matches its Crossref record; 265 of the 265 references it cites were found in a registry or an index.
Small Cell Lung Cancer
Open accessAbstract
Neuroendocrine tumors account for approximately 20% of lung cancers; most (≈15%) are small cell lung cancer (SCLC). These NCCN Clinical Practice Guidelines in Oncology for SCLC focus on extensive-stage SCLC because it occurs more frequently than limited-stage disease. SCLC is highly sensitive to initial therapy; however, most patients eventually die of recurrent disease. In patients with extensive-stage disease, chemotherapy alone can palliate symptoms and prolong survival in most patients; however, long-term survival is rare. Most cases of SCLC are attributable to cigarette smoking; therefore, smoking cessation should be strongly promoted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–265 of 265
Delisle, L. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.6.746 · Cited by 96
Reck, M., von Pawel, J., Macha, H.-N., Kaukel, E., Deppermann, K.-M., Bonnet, R. B., Ulm, K., Hessler, S., & Gatzemeier, U. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg017 · Cited by 95
The molecular and cellular basis of human lung cancer.
Gazdar, A. F. (1994) · PubMed · Cited by 94
Leukoencephalopathy in Small Cell Lung Cancer Patients Receiving Prophylactic Cranial Irradiation
Frytak, S., Shaw, J. N., O’Neill, B. P., et al. (1989) · American Journal of Clinical Oncology · doi:10.1097/00000421-198902000-00007 · Cited by 93
Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer
Eckardt, J. R., Bentsion, D., Lipatov, O. N., Polyakov, I. S., MacKintosh, F. R., Karlin, D. A., Baker, G. S., & Breitz, H. B. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.3235 · Cited by 92
Dimopoulos, M. A., Fernandez, J. F., Samaan, N. A., Holoye, P. Y., & Vassilopoulou‐Sellin, R. (1992) · Cancer · Cited by 91
Gross, A. J., Sm, S., Jg, R., Dp, B., Brennan, J., Pt, L., Simmons, A., Phelps, R. M., Mulshine, J. L., & Ihde, D. C. (1993) · PubMed · Cited by 90
Systemic diseases associated with disorders of water homeostasis
Wong, L. L., & Verbalis, J. G. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(01)00007-x · Cited by 89
Okamoto, H., Watanabe, K., Nishiwaki, Y., Mori, K., Kurita, Y., Hayashi, I., Masutani, M., Nakata, K., Tsuchiya, S., Isobe, H., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3540 · Cited by 89
Kosmidis, P., Samantas, E., Fountzilas, G., Pavlidis, N., Apostolopoulou, F., & Skarlos, D.-V. (1994) · PubMed · Cited by 88
Results of combined‐modality therapy for limited‐stage small cell lung carcinoma in the elderly
Schild, S. E., Stella, P. J., Brooks, B. J., Mandrekar, S. J., Bonner, J. A., McGinnis, W. L., Mailliard, J. A., Krook, J. E., Deming, R. L., Adjei, A. A., et al. (2005) · Cancer · doi:10.1002/cncr.21034 · Cited by 86
Ectopic ACTH syndrome: Molecular bases and clinical heterogeneity
Terzolo, M., Reimondo, G., Alì, A., Bovio, S., Daffara, F., Paccotti, P., & Angeli, A. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s83 · Cited by 86
Murray, N., Grafton, C., Shah, A., Gelmon, K. A., Kostashuk, E. C., Brown, E., Coppin, C., Coldman, A. J., & Page, R. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3323 · Cited by 86
Spigel, D. R., Greco, F. A., Zubkus, J. D., Murphy, P. B., Saez, R. A., Farley, C. P., Yardley, D. A., Burris, H. A., & Hainsworth, J. D. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181bbc540 · Cited by 85
Jacoby, J. J., Erez, B., Korshunova, M. V., Williams, R. R., Furutani, K., Takahashi, O., Kirkpatrick, L., Lippman, S. M., Powis, G., O'Reilly, M. S., et al. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181dc211f · Cited by 84
Olejniczak, E. T., Sant, C. V., Anderson, M. G., Wang, G. G., Tahir, S. K., Sauter, G., Lesniewski, R., & Semizarov, D. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0367 · Cited by 80
Sculier, J., Paesmans, M., Bureau, G., Dabouis, G., Libert, P., Vandermoten, G., Cutsem, O. V., Berchier, M. C., Ries, F., & Michel, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.10.1858 · Cited by 78
Tahir, S. K., Wass, J. A. H., Joseph, M. K., Devanarayan, V., Hessler, P., Zhang, H., Elmore, S. W., Kroeger, P. E., Tse, C., Rosenberg, S. H., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0651 · Cited by 78
Polymorphisms of UDP-Glucuronosyltransferase and Pharmacokinetics of Irinotecan
Ando, Y., Ueoka, H., Sugiyama, T., Ichiki, M., Shimokata, K., & Hasegawa, Y. (2002) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200202000-00018 · Cited by 77
Paik, P. K., Rudin, C. M., Brown, A. B., Rizvi, N. A., Takebe, N., Travis, W. D., James, L. P., Ginsberg, M. S., Juergens, R. A., Markus, S., et al. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1265-5 · Cited by 75
Self-citationA Prospective Study of Patients with Lung Cancer and Hyponatremia of Malignancy
Johnson, B. E., Chute, J. P., Rushin, J. M., Williams, J. P., Le, P. T., Venzon, D. J., & Richardson, G. E. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.5.96-10075 · Cited by 75
Small cell lung cancer in Norway. Should more patients have been offered surgical therapy?
Rostad, H. (2004) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2004.06.011 · Cited by 74
Ou, S. I., & Zell, J. A. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318194a355 · Cited by 73
Ardizzoni, A., Manegold, C., Debruyne, C., Gaafar, R. M., Buchholz, E., Smit, E. F., LIANES, P., ten Velde, G. P. M., Bosquée, L., Legrand, C., et al. (2003) · PubMed · Cited by 72
Meriney, S. D., Hulsizer, S., Grinnell, A. D., & Lennon, V. A. (1996) · Annals of Neurology · doi:10.1002/ana.410400510 · Cited by 71
Tim, R. W., Massey, J. M., & Sanders, D. B. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb11024.x · Cited by 71
Sculier, J., Paesmans, M., Bureau, G., Giner, V., Lecomte, J., Michel, J., Berchier, M. C., Cutsem, O. V., Küstner, U., Kroll, F., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.8.2337 · Cited by 70
Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells
Toi, M., Jones, C., & Kane, M. A. (1996) · Lung Cancer · doi:10.1016/0169-5002(95)00597-8 · Cited by 70
Oral Etoposide and Carboplatin: Effective Therapy for Elderly Patients with Small Cell Lung Cancer
Evans, W. K., Radwi, A., Tomiak, E. M., Logan, D. M., Martins, H., Stewart, D. J., Goss, G., Maroun, J., & Dahrouge, S. (1995) · American Journal of Clinical Oncology · doi:10.1097/00000421-199504000-00011 · Cited by 69
Hanna, N. H., Sandler, A. B., Loehrer, P. J., Ansari, R., Jung, S., Lane, K. A., & Einhorn, L. H. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf014 · Cited by 69
Unique anti-activator protein-1 activity of retinoic acid receptor beta.
Lin, F., Xiao, D., Kolluri, S. K., & Zhang, X. (2000) · PubMed · Cited by 68
Party, F. T. E. L. C. W., Jp, S., Paesmans, M., Lecomte, J., Cutsem, O. V., Lafitte, J., Berghmans, T., Koumakis, G., Florin, M., Thiriaux, J., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2114 · Cited by 67
The molecular pathogenesis of small cell lung cancer
D’Angelo, S. P., & Pietanza, M. C. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.1.12045 · Cited by 67
Goodman, G. E., Crowley, J. J., Blasko, J. C., Livingston, R. B., BECK, T. M., Demattia, M. D., & Bukowski, R. M. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.1.39 · Cited by 67
Kamoi, K., Ebe, T., Kobayashi, O., Ishida, M., Sato, F., Okuhiro, A. R. A. I., Tamura, T., TAKAGI, A., Ishibashi, M., & YAMAJI, T. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-5-1385 · Cited by 64
Weiss, R. H., RAMIREZ, A., & Joo, A. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1091880 · Cited by 64
Westeel, V., Murray, N., Gelmon, K. A., Shah, A., Sheehan, F., McKenzie, M. R., Wong, F., Morris, J., Grafton, C., Tsang, V., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1940 · Cited by 62
Pathology of small cell carcinoma of the lung
Zakowski, M. F. (2003) · Seminars in Oncology · doi:10.1053/sonc.2003.50015 · Cited by 60
Wolff, N. C., Randle, D. E., Egorin, M. J., Minna, J. D., & Ilaria, R. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0957-03 · Cited by 60
Johnson, B. E., Whang‐Peng, J., Naylor, S. L., et al. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.16.1223 · Cited by 60
Src Inhibitors in Lung Cancer: Current Status and Future Directions
Rothschild, S. I., Gautschi, O. P., Haura, E. B., & Johnson, F. M. (2010) · Clinical Lung Cancer · doi:10.3816/clc.2010.n.030 · Cited by 59
Hong, W. K., Nicaise, C., Lawson, R. D., Maroun, J. A., Comis, R. L., Speer, J. F., Luedke, D. W., Hurtubise, M., Lanzotti, V. J., & Goodlow, J. L. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.4.450 · Cited by 58
Coe, B. P., Lee, E. H. L., Chi, B., Girard, L., Minna, J. D., Gazdar, A. F., Lam, S. C., MacAulay, C. E., & Lam, W. L. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20260 · Cited by 58
Ioannou, M., Papamichali, R., Kouvaras, E., Mylonis, I., Vageli, D., Kerenidou, T., Barbanis, S., Daponte, A., Simos, G., Gourgoulianis, K., et al. (2009) · Lung · doi:10.1007/s00408-009-9169-z · Cited by 57
Verbalis, J. G., Zeltser, D., Smith, N. N., Barve, A. J., & Andoh, M. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03149.x · Cited by 57
Beith, J. M., Clarke, S. J., Woods, R. L., Bell, D. R., & Levi, J. A. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00608-7 · Cited by 57
Second-line chemotherapy in recurrent small cell lung cancer
Sundstrøm, S. H., Bremnes, R. M., Kaasa, S., Aasebø, U., & Aamdal, S. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.10.016 · Cited by 56
Simon, G. R., Ginsberg, R. J., & Jc, R. (2001) · PubMed · Cited by 56
Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer
Matsui, K., Masuda, N., Fukuoka, M., Yana, T., Hirashima, T., Komiya, T., Kobayashi, M., Kawahara, M., Atagi, S., Ogawara, M., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.325 · Cited by 55
PARANEOPLASTIC SYNDROMES ASSOCIATED WITH SMALL CELL LUNG CANCER
Marchioli, C. C., & Graziano, S. L. (1997) · Chest Surgery Clinics of North America · doi:10.1016/s1052-3359(25)00777-x · Cited by 54
Secretion of atrial natriuretic peptide and vasopressin by small cell lung cancer
Campling, B. G., Sarda, I. R., Baer, K. A., Pang, S. C., Baker, H. M., Lofters, W. S., & Flynn, T. G. (1995) · Cancer · doi:10.1002/1097-0142(19950515)75:10<2442::aid-cncr2820751009>3.0.co;2-q · Cited by 54
Prins, J., Vries, E. G. D., & Mulder, N. H. (1993) · PubMed · Cited by 53
Hirsch, F. R., Hansen, H. H., Hansen, M., Østerlind, K., Vindeløv, L. L., Dombernowsky, P., & Sørensson, S. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.4.585 · Cited by 52
CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer
Fukuoka, M., Masuda, N., Negoro, S., Matsui, K., Yana, T., Kudoh, S., Kusunoki, Y., Takada, M., Kawahara, M., Ogawara, M., et al. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.50 · Cited by 51
Miller, A. A., Pang, H., Hodgson, L. C., et al. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181cee36e · Cited by 50
Lima, J. P. D. S. N., dos Santos, L. V., Sasse, E. C., Lima, C. S. P., & Sasse, A. D. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f2451c · Cited by 50
Akl, E. A., van Doormaal, F. F., Barba, M., et al. (2008) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-27-4 · Cited by 47
Edelman, M. J., Chansky, K., Gaspar, L. E., Leigh, B. R., Weiss, G. R., Taylor, S. A., Crowley, J. J., Livingston, R. B., & Gandara, D. R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.070 · Cited by 46
Oral anticoagulation for prolonging survival in patients with cancer
Akl, E. A., Kamath, G., Kim, S. C., Yosuico, V. E. D., Barba, M., Terrenato, I., Sperati, F., & Schünemann, H. J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006466 · Cited by 44
Management of small cell lung cancer
Johnson, B. E. (2002) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(03)00070-4 · Cited by 41
Radiotherapy in Small-Cell Lung Cancer: Lessons Learned and Future Directions
Slotman, B. J., & Senan, S. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.10.039 · Cited by 36
Maintenance chemotherapy in limited small cell lung cancer: a randomised controlled clinical trial
Byrne, M., van Hazel, G., Trotter, J., Cameron, F., Shepherd, J., Cassidy, B., & Gebski, V. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.296 · Cited by 35
New drugs for chemotherapy-naive patients with extensive-disease small cell lung cancer
Ettinger, D. S. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90075-2 · Cited by 33
Taking care of smoker cancer patients: a review and some recommendations
Mazza, R., Lina, M., Boffi, R., Invernizzi, G., Marco, C. D., & Pierotti, M. A. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp599 · Cited by 26
The polymerase chain reaction and cancer diagnostics
Lyons, J. F. (1992) · Cancer · doi:10.1002/1097-0142(19920315)69:6+<1592::aid-cncr2820691315>3.0.co;2-r · Cited by 12
Cited by
Lung cancer immunotherapy: progress, pitfalls, and promises
Lahiri, A., Maji, A., Potdar, P. D., Singh, N., Parikh, P., Bisht, B., Mukherjee, A., & Paul, M. K. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01740-y · Cited by 1,102
Chaudhuri, A. A., Chabon, J. J., Lovejoy, A. F., Newman, A. M., Stehr, H., Azad, T. D., Khodadoust, M. S., Esfahani, M. S., Liu, C. L., Zhou, L., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0716 · Cited by 1,072
Self-citationOser, M. G., Niederst, M. J., Sequist, L. V., & Engelman, J. A. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71180-5 · Cited by 942
Mollaoglu, G., Guthrie, M. R., Böhm, S., Brägelmann, J., Can, I., Ballieu, P. M., Marx, A., George, J., Heinen, C., Chalishazar, M. D., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.12.005 · Cited by 588
Rudin, C. M., Pietanza, M. C., Bauer, T. M., Ready, N., Morgensztern, D., Glisson, B. S., Byers, L. A., Johnson, M. L., Burris, H. A., Robert, F., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30565-4 · Cited by 574
Self-citation
Metadata
- Authors
- Kalemkerian, G. P., Akerley, W., Bogner, P., Borghaei, H., Chow, L. Q., Downey, R. J., Gandhi, L., Ganti, A. K. P., Govindan, R., Grecula, J. C., Hayman, J., Heist, R. S., Horn, L., Jahan, T., Koczywas, M., Loo, B. W., Merritt, R. E., Moran, C. A., Niell, H. B., O’Malley, J., Patel, J. D., Ready, N., Rudin, C. M., Williams, C. C., Gregory, K., & Hughes, M.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2013-01
- Volume
- 11
- Issue
- 1
- Pages
- 78-98
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W2117569715
- Cited by
- 436
- References
- 265
- FWCI
- 16.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.